Magnetic nanoparticles (MNPs) with proper surface functionalization have been extensively applied as labels for magnetic immunoassays, carriers for controlled drug/gene delivery, tracers and contrasts for magnetic imaging, etc. Here, we introduce a new biosensing scheme based on magnetic particle spectroscopy (MPS) and the selfassembly of MNPs to quantitatively detect H1N1 nucleoprotein molecules. MPS monitors the harmonics of oscillating MNPs as a metric for the freedom of rotational motion, thus indicating the bound states of MNPs.
time is less than 30 min with high specificities (95 -99%), the sensitivities of the RIDTs are lower than other techniques (10 -70%) and false negative results should be considered. [17, 18] Giant magnetoresistive (GMR) biosensors have also been reported for the detection of IAV both in lab-based and point-of-care platforms. [19] [20] [21] However, this technique is limited by the complexity of nanofabricating the GMR sensors as well as the cost per chip/test.
Magnetic particle spectroscopy (MPS), a novel measurement tool that closely related to magnetic particle imaging (MPI), has emerged recent years as an alternative to the aforementioned techniques and is gaining increasing attentions in the area of volumetric-based bioassays. [22] [23] [24] [25] [26] In MPS, also called 0D MPI, oscillating magnetic fields periodically drive magnetic nanoparticles (MNPs) into saturated states where the magnetic responses contain not only the fundamental driving field frequencies but also a series of harmonic frequencies.
These harmonics are very useful metrics for characterizing the MNP ferrofluids such as the viscosity and temperature of the solution as well as the conjugations of chemical compounds on the MNPs. [26] [27] [28] [29] [30] [31] Nowadays, with the ease of fabricating and surface-functionalizing MNPs, MNPs functionalized with ligands, DNA, RNA, and protein molecules can be readily applied as probes, labels, contrasts, and tracers for different bioassays. [26, [31] [32] [33] [34] [35] [36] [37] [38] [39] Unlike the surface-based biosensing platforms (ELISA, GMR, Hall effect sensors, etc.) that directly detect individual target objects near the sensing elements, the volumetric-based biosensing platforms measure the analytical signals that directly come from the entire detection volume, making the bioassays simple and fast. [40] [41] [42] [43] Representative examples of volumetric-based sensors are the conventional superconducting quantum interference devices (SQUIDs), the nuclear magnetic resonance (NMR) devices, and the magnetic susceptometers. [44] [45] [46] [47] [48] [49] [50] MPS is one type of volumetric-based biosensing platform where the MNPs are acting as the mini-sensing probes and their dynamic magnetic responses are used as metrics for the characterization of target analytes from the fluidic samples. [51] [52] [53] [54] [55] 
Results and Discussion

Conjugating IgG Polyclonal Antibodies on MNPs.
To immobilize rabbit IgG polyclonal antibodies onto MNPs, the zero-length carbodiimide crosslinker EDC is used to couple the carboxyl groups from MNPs to the primary amines from IgG. As shown in Figure 1 (a):i -iii, the EDC reacts with carboxylic acid group from MNP to form an O-acylisourea active ester that can be easily displaced by nucleophilic attack from primary amino group on IgG. In this step, 1.5 mL microcentrifuge tube containing 200 L, 0.29 nmole/mL SHP-25 MNP suspension is mixed with 200 L, 25 mM MES and 10 L, 10 mg/mL EDC, react at room temperature for 15 min with continuous mixing. Then, 100 L, 5 g/mL polyclonal IgG is added to the suspension and react at room temperature for 2.5 hours with continuous mixing. As is shown in Figure 1 
The Experimental and Control Groups.
As shown in Figure 1 (c), to the as-prepared MNP-IgG samples I -VII were added 100 L H1N1 nucleoprotein of varying concentrations (from 4.42 M down to 44 nM as listed in Table 1 ). To sample VIII, 100 L PBS buffer was added (instead of antigen) as negative control group #1 (denoted as '0 nM (MNP+Aby)' in this paper).
Sample IX containing 100 L, 0.29 nmole/mL SHP-25 MNP and 100 L PBS buffer (without antibody or H1N1 nucleoprotein) is prepared as negative control group #2 (denoted as 'Bare MNP' in this paper). Samples I -IX are incubated at room temperature for 2 hours with continuous mixing to allow the cross-linking of MNPs and H1N1 nucleoprotein molecules, followed by storage at 2C -8C under sterile condition before the MPS measurements. 
Self-Assembly of MNPs.
Different degrees of MNP self-assemblies (here different degrees indicate the number and average sizes of MNP self-assemblies) are formed in samples I -VII due to the fact that the H1N1 nucleoprotein molecule has multiple epitopes recognized by polyclonal antibodies (see Figure 1(b) ). As a result, each H1N1 nucleoprotein is bound to more than one MNPs. On the other hand, each MNP functionalized with multiple IgG polyclonal antibodies is able to bind with multiple H1N1 nucleoprotein molecules. Thus, the cross-linking of MNPs and H1N1
nucleoproteins leads to different degrees of MNP self-assemblies depending on the number/concentration of H1N1 nucleoproteins in the MNP ferrofluid.
Detection of H1N1 Nucleoprotein via MPS and Magnetic Relaxation Dynamics.
When The description of our lab-based MPS system setup can be found in Supporting Information Note S1 and a representative signal chain is shown in Figure 1(d) . The frequency of the high-frequency driving field is swept from 400 Hz to 20 kHz, and the frequency of the low-frequency driving field is set at 10 Hz. The amplitudes of the high-and low-frequency driving fields are set at 17 Oe and 170 Oe, respectively. The sampling rate is set at 500 kHz. In each MPS measurement, the background noise floor is collected As the harmonics are largely dependent on the number of MNPs from the sample, the MPS results could be biased by the deviations of MNP quantities from one sample to another, especially for the detection of very low concentration target biomarkers. Besides the metrics of the 3 rd and the 5 th harmonics for the characterization of H1N1 nucleoproteins. The harmonic ratio, R35, has also been proposed as MNP quantity-independent metric for the detection of biomarkers (see Notes S7 from Supporting Information). [26, 31, 56] Herein, the harmonic ratios R35 from samples I -IX at various driving field frequencies are summarized in Figure 3 Table 2 . Again, there is a clear trend that the R35 value decreases as the concentration of H1N1 nucleoprotein increases. 
Hydrodynamic Size Analysis on the MNP Self-Assemblies.
The hydrodynamic sizes of the samples are characterized by Dynamic Light Scatter (DLS, Microtrac NanoFlex). nm to 300 nm) which is highlighted in the blue area from Figure 5 (a) -(e) as well as the black square in Figure 5 (f). The tail shows the largest peak in sample II which gradually diminishes in the consecutive samples with little to no peak in the sample IX. The black dashed lines in Figure 5 (a) -(e) are the log-normal curve fittings of the particle sizes from samples II, IV, VI, VIII, and IX. The relaxation dynamics of MNPs are dependent on the balance between the magnetic forces that tend to align the magnetic moments of MNPs along the external magnetic field direction and the thermal fluctuations that hinder the alignments. Relaxation time models are used to characterize these mechanisms.
Zero-field Brownian relaxation time is expressed as:
where is the viscosity of ferrofluid, is Boltzmann constant, is temperature, and ℎ is the hydrodynamic volume of nanoparticles. In this paper, iron oxide nanoparticles with magnetic core diameters and surface chemical compounds thickness of are assumed. So, ℎ = ( + 2 ) 3 6 ⁄ .
Zero-field Néel relaxation time is expressed as:
where,
where is electron gyromagnetic ratio (1.76 × 10 11 ⁄ ), ′ is damping constant, which is typically on the order of 10 −3~1 0 −2 for bulk materials. [3] While fine particles have larger damping constants than bulk, usually ′ = 0.1 for iron oxide nanoparticles. [2] ∆ is the energy barrier a nanoparticle needs to overcome before flipping from one minimum energy state to the other minimum energy state. Magnetic core volume = 3 6 ⁄ .
For MPS measurements, external magnetic fields are applied to the MNP ferrofluid systems. Hence, the zerofield relaxation time equations aforementioned do not apply in this case. These equations only give us the time for net magnetization to relax back to equilibrium after the removal of external magnetic fields. [2] As is reported before, the relaxation time is not only dependent on the externally applied magnetic field strength but also dependent on the field frequency. [4] Analytical expression for Brownian relaxation time at nonzero field is: [5] = 0
Analytical expression for Néel relaxation time at nonzero field is: [6] S-4
where and ℎ are time-varying parameters modulated by external magnetic field ( ):
As we apply a periodically varying external magnetic field ( ) to the ferrofluid system, the relaxation time and will also show a periodical change synchronously.
The magnetization dynamics of MNPs are usually characterized by effective relaxation time , which is S-9
Note S7. The 3 rd over the 5 th Harmonic Ratio (R35) as MNP Quantity-Independent Metric
Harmonic ratio of the 3 rd over the 5 th harmonics is expressed as: 
Hence, one advantage of using this harmonic ratio to characterize magnetic properties of MNPs is that this parameter is independent of concentration/quantity of MNPs in the testing sample.
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Note S8. The R35 Heatmap Figure S2 . The heatmap of R35 values at combinational H1N1 nucleoprotein concentrations and driving field frequencies.
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Note S9. Capabilities of the 3 rd Harmonic, the 5 th Harmonic, and the Harmonic Ratio R35 as Metrics for Distinguishing H1N1 Nucleoprotein Samples with High and Low Concentrations.
It should be noted that both the 3 rd and 5 th harmonics show significantly weaker capabilities in detecting low concentrations of H1N1 nucleoprotein (see the red curves in Figure S3(a) & (b) ). Under the driving field frequency of 1 kHz, the differences in 3 rd harmonic amplitudes measured from samples VII (44 nM) and VIII (0 nM) is only 2.8%, this difference increases to 3.9% at a driving field frequency of 5 kHz (see Figure S3(a) ).
Similarly, the differences in 5 th harmonic amplitudes from samples VII (44 nM) and VIII (0 nM) is only 2.6% at 1 KHz and increases to 3.1% at 5 kHz (see Figure S3( 
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On the other hand, the harmonic ratio R35 demonstrates comparable capabilities in distinguishing high and low concentrations of H1N1 nucleoprotein samples (see Figure S3(c) ). For the detection of samples with low concentrations of H1N1 nucleoproteins, the R35 differences from samples VII (44 nM) and VIII (0 nM) increase from 0.14% to 1.02% from 1 kHz to 5 kHz. At the higher end of H1N1 nucleoprotein concentrations, the harmonic ratio R35 shows stronger capability in distinguishing samples I (4.42 µM) and II (2.21 µM) with differences of 1.33% and 0.97% at 10 kHz and 15 kHz, respectively (see the red curve in Figure S3(c) ). I  II  III  IV  V  VI  VII  VIII  IX 
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